Rachel Saavedra
Family · Las Cruces, NMNPI 1568786820
Payments from drug & device makers
What this record shows
AbbVie accounts for 79.1% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $1,702, more than ten times the $159 reported in 2021. Among family clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $65.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Neurocrine Biosciences, Inc.$169
- Abbott$133
- AstraZeneca$112
- Silk Road Medical, Inc.$94
- Lilly USA, LLC$86
- plus $133 from 4 others
What the payments were for
- Speaking & faculty fees$2,07260%
- Food & beverage$1,40740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $2,751 |
| Neurocrine Biosciences, Inc. | 3 | $169 |
| Abbott | 1 | $133 |
| AstraZeneca | 1 | $112 |
| Silk Road Medical, Inc. | 1 | $94 |
| Lilly USA, LLC | 5 | $86 |
| Novo Nordisk | 3 | $55 |
| Corium, LLC | 2 | $46 |
| Exact Sciences | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,478 in reported general payments places this provider in the 90th percentile of 1,080 family providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 22 | $635 |
| Atorvastatin Calcium | 40 | $473 |
| Levothyroxine Sodium | 34 | $471 |
| Losartan Potassium | 23 | $201 |
| Metformin Hcl | 18 | $128 |
| Lisinopril | 14 | $86 |
| Amlodipine Besylate | 14 | $78 |
Paid to pharmacies, not to this prescriber.
Other family in Las Cruces
- Jamie LujanLas Cruces$14K
- Joleen LeszczynskiLas Cruces$8K
- Deborah PachecoLas Cruces$6K
- Angelina CarverLas Cruces$5K
- Russell CoryellLas Cruces$5K
- Jessica AltamiranoLas Cruces$5K
- Laura OrtegaLas Cruces$4K
- Thomas HaythLas Cruces$3K
- David SeiterFarmington$194K
- Carol HollandRoswell$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.